Dr. Panella is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1926 Alcoa Hwy
Ste 410
Knoxville, TN 37920Phone+1 865-305-8780Fax+1 865-305-8199
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 1986 - 1989
- UMass Chan Medical SchoolResidency, Internal Medicine, 1983 - 1986
- University of Tennessee Health Science Center College of MedicineClass of 1983
Certifications & Licensure
- TN State Medical License 1991 - 2025
- NC State Medical License 1986 - 1992
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Join now to see all
Publications & Presentations
PubMed
- 60 citationsDifferential molecular mechanism of the estrogen action that regulates lactoferrin gene in human and mouse.Christina T. Teng, Youhua Liu, Nengyu Yang, David K. Walmer, Timothy J. Panella
Molecular Endocrinology. 1992-11-01 - 124 citationsPhase II Trial of a Single Weekly Intravenous Dose of Ranpirnase in Patients With Unresectable Malignant MesotheliomaStanislaw M. Mikulski, John J. Costanzi, Nicholas J. Vogelzang, Spence McCachren, Robert N. Taub
Journal of Clinical Oncology. 2002-01-01 - 61 citationsPrognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.N. Lynn Ferguson, John L. Bell, Robert E. Heidel, Solomon Lee, Stuart VanMeter
The Breast Journal. 2013-01-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: